For those interested in the role governance plays in the development of precision medicine, this article is for you! 

A new report from the Brookings Institution explores how agile governance can help promote innovation in precision medicine while protecting the public from unintended consequences. Precision medicine uses personal information, such as DNA sequences, to prevent, diagnose, and treat disease. This can present significant challenges, including genomic data privacy, clinical trial design, and equitable therapeutic delivery. The report presents global case studies demonstrating how governments, companies, and other stakeholders use agile governance processes related to healthcare and asks what the implications could be for precision medicine.

Key findings were that a combination of technological, ethical, and regulatory challenges limited precision medicine's impact. Investment in health care innovation is vital to overcome this, but the risks need to be managed with agile governance. Governments should work with industry, build on best practices, and collaborate internationally to accelerate innovation ethically.

If you want more detailed information surrounding agile governance and precision medicine, click the link to read more from the World Economic Forum.